Only young, healthy strength athletes take part in the study
Conditions
Interventions
Group 1: Strength training + commercial ecdysterone and diosgenin product from weider (Beta Ecdysterone)
Group 2: strength training + placebo
Sponsors
IST Hochschule für Management
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: healthy, resistance-trained young men and women
Exclusion criteria
Exclusion criteria: Orthopaedic abnormalities in the spine, pelvis, shoulders or legs as well as psychological abnormalities in the form of an eating disorder. In addition, there should be no metabolic or cardiovascular diseases or the need for regular medication.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Blood tests to check hormone changes and liver and kidney activity: Measurements are only taken at T0 and T3: Hormone parameters: Testosterone, estradiol, cordisol, IGF-1 | — |
Primary
| Measure | Time frame |
|---|---|
| Change in body composition and performance: Measurements are taken every 4 weeks (T0, T1 (+4 weeks), T2 (+8 weeks), T3 (post, +12 weeks) Body composition is measured via bioelectrical impedance analysis (BIA Akern 101) Parameters collected: Fat-free mass, muscle mass, fat mass and water balance. Performance is determined in the squat and bench press by means of a repetition maximum | — |
Countries
Germany
Contacts
Public ContactEduard Isenmann
IST Hochschule für Management
Outcome results
None listed